Brief: Merck In Late-Stage Talks To Acquire Prometheus Biosciences - WSJ
16/04/2023 05:04
April 16 (Reuters) -
* MERCK IN LATE-STAGE TALKS TO ACQUIRE PROMETHEUS
BIOSCIENCES -
WSJ
Source text: [https://on.wsj.com/43A596O]
Further company coverage: MRK.N
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Prometheus Biosciences
See all newsBrief: Prometheus Biosciences - Completed Merger Of Splash Merger Sub, Unit Of Merck & Co
Analysis: Amgen's antitrust woes spur wider pharmaceutical deal fears
William Blair sees FTC suit on Amgen-Horizon deal weighing on biotech M&A sentiment
FTC scrutiny to block Amgen-Horizon deal drags down Seagen, Prometheus
Brief: Prometheus Biosciences Reports First Quarter 2023 Financial Results